Results 121 to 130 of about 691 (170)

Structural and functional evolution of IL-1 targeting: From systemic neutralization to bioengineered nanotherapies. [PDF]

Mater Today Bio
Yang L, Chen G, Lyu Z.
europepmc   +1 more source

Expression Analysis of Heavy-Chain-Only Antibodies in Cloudy Catshark and Japanese Bullhead Shark. [PDF]

Mar Drugs
Uemura R, Tanimura S, Yamaguchi N, Kuroiwa R, Andrés Tsutsumi GT, Fujikawa T, Soyano K, Takeda K, Tanaka Y.   +8 more
europepmc   +1 more source

18P Targeting MET-expressing NSCLC with a VNAR-based theranostic agent

ESMO Open
J. West, R. Minne, K. Nickel, G. Gunaratne, R. Hernandez, A. Baschnagel, R. Kimple, A. Lebeau   +7 more
openaire   +1 more source

Modeling and optimization of hydrogenation for crude oil by estimating hydrogen solubility in the solvent at different temperatures. [PDF]

Front Chem
Zhao Z.
europepmc   +1 more source

Marine Natural Products as Anticancer Agents 3.0. [PDF]

Mar Drugs
Alves C, Diederich M.
europepmc   +1 more source

Nanobody fusion enhances production of difficult-to-produce secretory proteins. [PDF]

J Biol Chem
Yan R, Zhang Y, Zhang H, Ma J.
europepmc   +1 more source

CAR-Toner: an AI-driven approach for CAR tonic signaling prediction and optimization. [PDF]

Cell Res
Qiu S, Chen J, Wu T, Li L, Wang G, Wu H, Song X, Liu X, Wang H.   +8 more
europepmc   +1 more source

PROSCA: an online platform for humanized scaffold mining facilitating rational protein engineering. [PDF]

Nucleic Acids Res
Wang X, Zhang Y, Li Z, Duan Z, Guo M, Wang Z, Zhu F, Xue W.   +7 more
europepmc   +1 more source